Usefulness of S100P in diagnosis of adenocarcinoma of pancreas on fine-needle aspiration biopsy specimens

American Journal of Clinical Pathology

Volumn 129, Issue 1, 2008, Pages 81-88

  Deng, Hongbing ^a   Shi, Jianhui ^a   Wilkerson, Myra ^a   Meschter, Steven ^a   Dupree, William ^a   Lin, Fan ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

Adenocarcinoma; Fine needle aspiration biopsy; Pancreas; S100P

Indexed keywords

BIOLOGICAL MARKER; CALCIUM BINDING PROTEIN; S100P CALCIUM BINDING PROTEIN; CARRIER PROTEIN; NUCLEAR PROTEIN; S100PBP PROTEIN, HUMAN; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; ASPIRATION BIOPSY; CANCER DIAGNOSIS; DIAGNOSTIC VALUE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SMEAR; DIFFERENTIAL DIAGNOSIS; ENZYME IMMUNOASSAY; EPITHELIUM CELL; METABOLISM; NEEDLE BIOPSY; PANCREAS CARCINOMA; PANCREAS DUCT; PANCREAS ISLET; PANCREAS ISLET CELL CARCINOMA; PANCREAS ISLET CELL TUMOR; PANCREAS TUMOR; PATHOLOGY;

ADENOMA, ISLET CELL; BIOPSY, FINE-NEEDLE; CARCINOMA, ISLET CELL; CARCINOMA, PANCREATIC DUCTAL; CARRIER PROTEINS; DIAGNOSIS, DIFFERENTIAL; EPITHELIAL CELLS; HUMANS; IMMUNOENZYME TECHNIQUES; ISLETS OF LANGERHANS; NUCLEAR PROTEINS; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 38449086071     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/5D76NDE81LE8G545     Document Type: Article

References (37)

1. Hruban RH, Pitman MB, Klimstra DS. Tumors of the Pancreas. Washington, DC: Armed Forces Institute of Pathology; 2007. Atlas of Tumor Pathology. Fourth series, fascicle 6.
2. Jemale A, Thomas A, Murray T, et al. Cancer statistics, 2002. CA Cancer J Clin. 2002;52:53-47.
3. Voss M, Hammel P, Molas G, et al. Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses. Gut. 2000;46:244-249.
4. Lin F, Staerkel G. Cytologic criteria for well differentiated adenocarcinoma of pancreas in fine-needle aspiration biopsy specimens. Cancer. 2003;99:44-50.
5. Cohen MB, Egerter DP, Holly EA, et al. Pancreatic adenocarcinoma: regression analysis to identify improved cytologic criteria. Diagn Cytopathol. 1991;7:341-345.
6. Mitchell ML, Carney CN. Cytologic criteria for the diagnosis of pancreatic carcinoma. Am J Clin Pathol. 1985;83:171-176.
7. Fekete PS, Nunez C, Pitlik DA. Fine-needle aspiration of the pancreas: a study of 61 cases. Diagn Cytopathol. 1986;2:301-306.
8. Robins DB, Katz RL, Evans DB, et al. Fine needle aspiration of the pancreas; in quest of accuracy. Acta Cytol. 1995;39:1-10.
9. Kocjan G, Rode J, Lees WR. Percutaneous fine needle aspiration of the pancreas: advantage and pitfalls. J Clin Pathol. 1989;42:341-347.
10. Al-Kaisi N, Siegler EE. Fine needle aspiration cytology of the pancreas. Acta Cytol. 1989;33:145-152.
11. Centeno BA, Pitman MB. Pancreatitis. In: Centeno BA, Pitman MB, eds. Fine Needle Aspiration Biopsy of the Pancreas. Boston, MA: Butterworth-Heinemann; 1999:31-51.
12. Mitchell ML, Bittner CA, Will JS, et al. Fine needle aspiration cytology of the pancreas: a retrospective study of 73 cases. Acta Cytol. 1988;32:447-451.
13. Alpern GA, Dekker A. Fine needle aspiration cytology of the pancreas: an analysis of its use in 52 patients. Acta Cytol. 1985;29:873-878.
14. Giovannini M, Seitz JF, Monges G, et al. Fine-needle aspiration cytology guided by endoscopic ultrasonography: results in 141 patients. Endoscopy. 1995;27:171-177.
15. Tada M, Komatsu Y, Kawabe T, et al. Quantitative analysis of K-ras gene mutation in pancreatic tissue obtained by endoscopic ultrasonography - guided fine needle aspiration: clinical utility for diagnosis of pancreatic tumor. Am J Gastroenterol. 2002;97:2263-2270.
16. van Heek T, Rader AE, Offerhaus GJ, et al. K-ras, p53 and DPC4 (MAD4) alterations in fine-needle aspirates of the pancreas: a molecular panel correlates with and supplements cytologic diagnosis. Am J Clin Pathol. 2002;117:755-765.
17. Nichols LS, Ashfaq R, Iacobuzio-Donahue CA. Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. Am J Clin Pathol. 2004;121:226-230.
18. McCarthy DM, Maitra A, Argani P, et al. Novel markers of pancreatic adenocarcinoma in fine-needle aspiration: mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases. Appl Immunohistochem Mol Morphol. 2003;11:238-243.
19. Chhieng DC, Benson E, Eltoum I, et al. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fineneedle aspiration. Cancer. 2003;99:365-371.
20. Yantiss RK, Woda BA, Fanger GR, et al. KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of pancreas. Am J Surg Pathol. 2005;29:188-195.
21. Iacobuzio-Donahue CA, Maitra A, Shen-Ong GL, et al. Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am J Pathol. 2002;160:1239-1249.
22. Iacobuzio-Donahue CA, Ashfaq R, Maitra A, et al. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res. 2003;63:8614-8622.
23. Iacobuzio-Donahue CA, Maitra A, Olsen M, et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol. 2003;162:1151-1162.
24. Logsdon CD, Simeone DM, Binkley C, et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res. 2003;63:2649-2657.
25. Crnogorac-Jurcevic T, Missiaglia E, Blaveri E, et al. Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent. J Pathol. 2003;201:63-74.
26. Becker T, Gerke V, Kube E, et al. S100P, a novel Ca (2+)-binding protein from human placenta: cDNA cloning, recombinant protein expression and Ca2+ binding properties. Eur J Biochem. 1992;207:541-547.
27. Dowen SE, Crnogorac-Jurcevic T, Gangeswaran R, et al. Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer. Am J Pathol. 2005;166:81-91.
28. Sato N, Fukushima N, Matsubayashi H, et al. Identification of mapsin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling. Oncogene. 2004;23:1531-1538.
29. Arumugam T, Simeone DM, Van Golen K, et al. S100P promotes pancreatic cancer growth, survival, and invasion. Clin Cancer Res. 2005;11:5356-5364.
30. Guerreiro Da Silva ID, Hu YF, Russo IH, et al. S100P calcium-binding protein overexpression is associated with immortalization of human breast epithelial cells in vitro and early stages breast cancer development in vivo. Int J Oncol. 2000;16:231-240.
31. Beer DG, Kardia SL, Huang CC, et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med. 2002;8:816-824.
32. Bertram J, Palfner K, Hiddenmann W, et al. Elevated expression of S100P, CAPL and MAGE3 in doxorubicin-resistant cell lines: comparison of mRNA differential display reverse transcription - polymerase chain reaction and subtractive suppressive hybridization for the analysis of differential gene expression. Anticancer Drugs. 1998;9:311-317.
33. Amler LC, Agus DB, LeDuc C, et al. Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1. Cancer Res. 2000;60:6134-6141.
34. Lin F, Yang W, Betten M, et al. Expression of S-100 protein in renal cell neoplasms. Hum Pathol 2006;37:462-470.
35. Pabst B, Arps S, Binmoeller K, et al. Analysis of K-ras mutations in pancreatic tissue after fine needle aspirates. Anticancer Res. 1999;19:2481-2483.
36. Maitra A, Ashfaq R, Gunn CR, et al. Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: an immunohistochemical analysis with automated cellular imaging. Am J Clin Pathol. 2002;118:194-201.
37. Lin F, Wang HL, Shi J, et al. Expression of S100A4, S100A6, and S100P in pancreatic and ampullary adenocarcinomas [abstract]. Mod Pathol. 2007;20(suppl 2):286A. Abstract 1313.